000234000 000__ 01481cam\a2200349\a\45e0
000234000 001__ 234000
000234000 005__ 20220217104335.0
000234000 008__ 980708s1998\\\\dcu\\\\\\b\\\f000\0\eng\c
000234000 010__ $$a   98167892
000234000 020__ $$a0160564980
000234000 035__ $$a(OCoLC)ocm39285367
000234000 035__ $$a234000
000234000 040__ $$aDGPO/DLC$$cDLC
000234000 043__ $$an-us---
000234000 049__ $$aISEA
000234000 05000 $$aKF27$$b.E5546 1998d
000234000 074__ $$a1019-A-01
000234000 074__ $$a1019-B-01 (MF)
000234000 0860_ $$aY 4.C 73/8:105-75
000234000 088__ $$aSerial no. 105-75 (United States. Congress. House. Committee on Commerce)
000234000 1101_ $$aUnited States.$$bCongress.$$bHouse.$$bCommittee on Commerce.$$bSubcommittee on Oversight and Investigations.
000234000 24510 $$aFood and Drug Administration management concerns :$$bhearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, second session, April 1, 1998.
000234000 260__ $$aWashington :$$bU.S. G.P.O. :$$bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,$$c1998.
000234000 300__ $$aiii, 71 p. ;$$c24 cm.
000234000 500__ $$aDistributed to some depository libraries in microfiche.
000234000 500__ $$aShipping list no.: 98-0248-P.
000234000 500__ $$a"Serial no. 105-75."
000234000 504__ $$aIncludes bibliographical references.
000234000 61020 $$aCenter for Biologics Evaluation and Research (U.S.)
000234000 61010 $$aUnited States.$$bFood and Drug Administration$$xManagement.
000234000 650_0 $$aPublic health$$zUnited States.
000234000 85230 $$bdfich$$hY 4.C 73/8:$$i105-75
000234000 909CO $$ooai:library.usi.edu:234000$$pGLOBAL_SET
000234000 980__ $$aBIB
000234000 980__ $$aGOV RESOURCE
000234000 994__ $$aE0$$bISE